The FDA has just approved a new treatment for food allergies using a monoclonal antibody called Xolair. In a study with children and adults age one and up who had peanut allergy and at least two other food allergies, injections of Xolair for 16 to 20 months increased the amount of food allergen that could…
The Cleveland Clinic recently reported the results of a study of oral immunotherapy in children ages under age four with peanut and other food allergies. Although there has been limited data on outcomes in this age group, this study found that 95% of children were successfully treated with OIT up to a full dose of 2…
Food Allergen Ingredient Labels – Can They Be Trusted? Peanut allergy puts a significant burden on peanut-allergic individuals as well as their families and decreases their quality of life. Reading every food ingredient label is essential in preventing a serious allergic reaction. Food labels stating “may contain trace amounts” or “made in the same facility”…
In a large study of peanut-allergic toddlers on OIT published recently in the prestigious medical journal The Lancet, 71% of treated children could safely consume the equivalent to nearly 17 peanuts after 2½ years on oral immunotherapy. Even after stopping treatment for the next 6 months, more than 1 in 5 maintained that level of…